Loading…

LTS LOHMANN Therapie-Systeme has successfully validated a semi-automated commercial production line for the Sorrel wearable drug delivery platform at its facility in Netanya, Israel. The company also announced plans to expand Sorrel production into Western markets.
“The new manufacturing line is just another step in our current manufacturing growth strategy.”ltslohmann.com
Summarized from public sources; check the original articles before acting on it.